{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-002835","form_type":"8-K","ticker":"PCSA","cik":"0001533743","company_name":"Processa Pharmaceuticals, Inc.","filed_at":"2024-01-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.528341+00:00","generated_at":"2026-06-06T21:54:18.636816+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Processa Pharmaceuticals to effect 1-for-20 reverse stock split to regain Nasdaq compliance","bullets":["Reverse split ratio 1-for-20, effective 12:01 a.m. ET Jan. 22, 2024.","Outstanding shares reduce from ~24.6M to ~1.2M.","No fractional shares; rounding up to nearest whole share.","Intended to regain compliance with Nasdaq $1 minimum bid price.","Stock continues trading under symbol PCSA with new CUSIP 74275C304."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-002835","json":"https://secwatch.observer/filing/0001493152-24-002835.json","markdown":"https://secwatch.observer/filing/0001493152-24-002835.md","text":"https://secwatch.observer/filing/0001493152-24-002835.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533743/000149315224002835/0001493152-24-002835-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533743/000149315224002835/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T21:54:18.636816+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0a3172ba164d8b58f843302cbe63b3218d16bfe8","claim":"Processa Pharmaceuticals, Inc.: Certificate of Amendment to Fourth Amended and Restated Certificate of Incorporation to effect a 1-for-20 reverse stock split (effective 2024-01-22).","evidence_excerpt":"On January 18, 2024, Processa Pharmaceuticals, Inc. (the “Company”) filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the “Certificate of Amendment”) to the Company’s Fourth Amended and Restated Certificate of Incorporation to effect a 1-for-20 reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding shares of common stock, par value $0.0001 per share (the “Common Stock”), effective as of 12:01 a.m. Eastern Time on January 22, 2024.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1533743/000149315224002835/0001493152-24-002835-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2024-01-22"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}